CTLA-4 mAb (9H10), InVivoPure

ID: AK3607P Category:

The CTLA-4 mAb clone 9H10 antibody recognizes cytotoxic T lymphocyte antigen-4 (CTLA-4) also known as CD152.

This antibody is produced exclusively under serum-free conditions from hybridoma and purified with Protein-A or Protein-G affinity chromatography.

In stock

Delivery time: 2-5 days

From: 130,00 € Excl. VAT and delivery costs

Please contact us for larger quantities.

Endotoxin level ≤ 2 EU/mg

The CTLA-4 mAb clone 9H10 antibody recognizes cytotoxic T lymphocyte antigen-4 (CTLA-4) also
known as CD152. Antibody 9H10 has shown specific reactivity against CTLA-4 Ig but not CD4 lg,
as well as the ability to block CTLA-4 Ig by binding to B7 transfected cells. Staining of activated
T cells, but not freshly isolated T cells, is reported, as well as the ability to stain a CTLA-4
transfectant but not control transfectants. The CTLA-4 mAb (9H10) antibody has shown
effectiveness in reducing tumor growth and metastasis in preclinical models. These
characteristics make the 9H10 antibody a reliable tool for identifying and studying CTLA-4 in
various immunological contexts.

This antibody is produced exclusively under serum-free conditions from hybridoma and
purified with Protein-A or Protein-G affinity chromatography.

 

Product-ID: AK3607P
Clone: 9H10
Immunogen: This antibody was raised by immunizing Syrian hamsters with heat-killed Staphylococcus A bacteria coated in CTLA-4.
Host: Syrian Hamster
Clonality: Monoclonal
Isotype: IgG
Formulation: Clear Liquid, PBS, pH 7.4, 0.2 μm sterile filtered
Concentration: ≥ 1.00 mg/mL
Purity: ≥ 90 % (CGE, reducing conditions)
≤ 10 % aggregates (analytical SEC)
Endotoxin: ≤ 2 EU/mg (LAL test)
Storage: 2 - 8 °C

 

The product is for research use or for further manufacturing only and not for use in diagnostic or therapeutic procedures.

Additional information

Literature

[1] Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J
Exp Med. 1995 Aug 1;182(2):459-65. doi: 10.1084/jem.182.2.459. PMID: 7543139; PMCID: PMC2192127.
[2] Demaria S, Kawashima N, Yang AM, Devitt ML, Babb JS, Allison JP, Formenti SC. Immune-mediated inhibition
of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.
Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):728-34. PMID: 15701862.

Document

Product Information Sheet – AK3607P

Notice

The product is for research use or for further manufacturing only and not for use in diagnostic or therapeutic procedures.

Reviews

There are no reviews yet.

Be the first to review “CTLA-4 mAb (9H10), InVivoPure”